Could this be the breakthrough to treating cancer?

A patient by name Bob Berry was diagnosed with lung cancer 3 years ago with an estimated 12-18 months to live but live expectancy was restored after new tests show no traces of cancer in his system after signing up for a clinical trials for a cancer treatment that is combined with immunotherapy to help bolster the immune system.
He's one of 12 people worldwide on clinical trials for the new drug.


Excerpt from Bob Berry's story:

Bob Berry, 60, was referred to one of the largest cancer treatment centres in Europe, The Christie, after which his unresponsiveness to chemotherapy which prompted Doctors to estimate his live expectancy to 12-18 months.

He agreed to clinical trials for new drug and was transfered to the hospital’s clinical trials unit, and 12 months ago Bob became one of the first people ever to be treated with the brand new drug.

 “Bob has had a phenomenal response to taking part in this clinical trial." - Dr Matthew Krebs, Bob’s consultant at The Christie.

“We will need to monitor Bob closely with regular scans to assess how durable this response will be.

“As it is a combined study with a brand new drug, we still have a lot of further research to do before we can establish how these findings can help more patients like Bob in the future as cancer is a complex disease and not every patient responds as well as this.” 

Bob spoke about his recovery saying:

“Three years ago, I was given 12 – 18 months to live but I have already surpassed that and I feel well."

"At the end of the day, this clinical trial at The Christie has extended my life and I couldn’t be more grateful. Anyone who is offered a clinical trial should seriously consider it.” 

Credit: Mirror.